Peter Pushko

Medigen, Inc.

$3,664,201

Attributed

$3,664,201

Total exposure

Grants

Lead (contact PI)

Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).

Funding over time

peak $2.2M · FY2011–25

$2.5M$1.9M$1.3M$625K$0

'11

'12

'13

'14

'15

'16

'17

'18

'19

'20

'21

'22

'23

'24

'25

Funding mix

By agency

NIH$3,664,201 · 2

By mechanism

N01$2,181,107 · 1

N44$1,483,094 · 1

Top collaborators

No co-investigators on record.

Most similar at Medigen, Inc.

Same institution · by research overlap

Peter M. Pushko$8,622,434

Others in their field

Top investigators on “Immunogenicity”

Margaret Juliana McElrath · Fred Hutchinson Cancer Center$489,963,650
Lawrence Corey · Fred Hutchinson Cancer Center$378,262,806
Barton F Haynes · Duke University$364,422,244
Dennis R. Burton · Scripps Research Institute$311,593,259
Peter B. Gilbert · Fred Hutchinson Cancer Center$200,471,907
Glenda E Gray · Wits Health Consortium (Pty), Ltd$172,054,560

Research focus

ImmunogenicitySafetyVaccinesAnimal ModelContractsCancer ImmunotherapyCancer ControlAntibody FormationCommunicable DiseasesCollaborationsFormulationDendritic CellsDesignDisease OutbreaksAssay DevelopmentEmerging Communicable DiseasesEfficacy TestingChemistryEngineeringEvaluationExpression VectorFollow-UpEfficacy EvaluationDose

Grant awards (2)

DEVELOPMENT OF A LASSA FEVER VIRUS VACCINE$2,181,107

N01 · FY2025 · AI · contact PI

SBIR TOPIC 255, PHASE II: SYNTHETIC VACCINES AGAINST PROSTATE CANCER$1,483,094

N44 · FY2011 · CA · contact PI